405 related articles for article (PubMed ID: 27275530)
41. Renal and adrenal masses containing fat at MRI: Proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma.
Schieda N; Davenport MS; Pedrosa I; Shinagare A; Chandarana H; Curci N; Doshi A; Israel G; Remer E; Wang J; Silverman SG
J Magn Reson Imaging; 2019 Apr; 49(4):917-926. PubMed ID: 30693607
[TBL] [Abstract][Full Text] [Related]
42. Intracellular lipid in clear cell renal cell carcinoma tumor thrombus and metastases detected by chemical shift (in and opposed phase) MRI: radiologic-pathologic correlation.
Moosavi B; Shabana WM; El-Khodary M; van der Pol CB; Flood TA; McInnes MD; Schieda N
Acta Radiol; 2016 Feb; 57(2):241-8. PubMed ID: 25681491
[TBL] [Abstract][Full Text] [Related]
43. CT histogram analysis: differentiation of angiomyolipoma without visible fat from renal cell carcinoma at CT imaging.
Kim JY; Kim JK; Kim N; Cho KS
Radiology; 2008 Feb; 246(2):472-9. PubMed ID: 18094264
[TBL] [Abstract][Full Text] [Related]
44. Computed Tomography and Magnetic Resonance Findings of Fat-Poor Angiomyolipomas.
Potretzke AM; Potretzke TA; Bauman TM; Knight BA; Park AM; Mobley JM; Figenshau RS; Siegel CL
J Endourol; 2017 Feb; 31(2):119-128. PubMed ID: 27897036
[TBL] [Abstract][Full Text] [Related]
45. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
[TBL] [Abstract][Full Text] [Related]
46. Renal cell carcinoma in patients with acquired cystic disease of the kidney: assessment using a combination of T2-weighted, diffusion-weighted, and chemical-shift MRI without the use of contrast material.
Akita H; Jinzaki M; Akita A; Mikami S; Oya M; Kuribayashi S
J Magn Reson Imaging; 2014 Apr; 39(4):924-30. PubMed ID: 24123320
[TBL] [Abstract][Full Text] [Related]
47. Fat poor angiomyolipoma differentiation from renal cell carcinoma at 320-slice dynamic volume CT perfusion.
Chen C; Kang Q; Xu B; Shi Z; Guo H; Wei Q; Lu Y; Wu X
Abdom Radiol (NY); 2018 May; 43(5):1223-1230. PubMed ID: 28828638
[TBL] [Abstract][Full Text] [Related]
48. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
49. CT negative attenuation pixel distribution and texture analysis for detection of fat in small angiomyolipoma on unenhanced CT.
Takahashi N; Takeuchi M; Sasaguri K; Leng S; Froemming A; Kawashima A
Abdom Radiol (NY); 2016 Jun; 41(6):1142-51. PubMed ID: 27015866
[TBL] [Abstract][Full Text] [Related]
50. Angiomyolipoma and renal cell carcinoma: US differentiation.
Siegel CL; Middleton WD; Teefey SA; McClennan BL
Radiology; 1996 Mar; 198(3):789-93. PubMed ID: 8628873
[TBL] [Abstract][Full Text] [Related]
51. Unenhanced CT for the diagnosis of minimal-fat renal angiomyolipoma.
Schieda N; Hodgdon T; El-Khodary M; Flood TA; McInnes MD
AJR Am J Roentgenol; 2014 Dec; 203(6):1236-41. PubMed ID: 25415700
[TBL] [Abstract][Full Text] [Related]
52. Differentiation between fat-poor angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
Ye J; Xu Q; Wang SA; Zheng J; Zhu QQ; Dou WQ
Abdom Radiol (NY); 2020 Feb; 45(2):512-519. PubMed ID: 31705246
[TBL] [Abstract][Full Text] [Related]
53. Differentiation of Angiomyolipoma With Minimal Fat from Clear Cell Renal Cell Carcinoma Using Non-contrast Multiparametric Magnetic Resonance Imaging.
Jomoto W; Takaki H; Yamamoto S; Kanematsu A; Igeta M; Hirota S; Yamakado K
In Vivo; 2022; 36(6):2790-2799. PubMed ID: 36309367
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology.
Kay FU; Canvasser NE; Xi Y; Pinho DF; Costa DN; Diaz de Leon A; Khatri G; Leyendecker JR; Yokoo T; Lay AH; Kavoussi N; Koseoglu E; Cadeddu JA; Pedrosa I
Radiology; 2018 May; 287(2):543-553. PubMed ID: 29390196
[TBL] [Abstract][Full Text] [Related]
55. Angiomyolipoma with minimal fat: differentiation of morphological and enhancement features from renal cell carcinoma at CT imaging.
Sung CK; Kim SH; Woo S; Moon MH; Kim SY; Kim SH; Cho JY
Acta Radiol; 2016 Sep; 57(9):1114-22. PubMed ID: 26663389
[TBL] [Abstract][Full Text] [Related]
56. Assessment of Imaging Findings of Renal Carcinoma Subtypes with 3.0T MRI.
Nalbant MO; Inci E
Niger J Clin Pract; 2023 Nov; 26(11):1750-1757. PubMed ID: 38044783
[TBL] [Abstract][Full Text] [Related]
57. Multiparametric MRI of solid renal masses: pearls and pitfalls.
Ramamurthy NK; Moosavi B; McInnes MD; Flood TA; Schieda N
Clin Radiol; 2015 Mar; 70(3):304-16. PubMed ID: 25472466
[TBL] [Abstract][Full Text] [Related]
58. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
59. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
[TBL] [Abstract][Full Text] [Related]
60. Angiomyolipoma (AML) without visible fat: Ultrasound, CT and MR imaging features with pathological correlation.
Hakim SW; Schieda N; Hodgdon T; McInnes MD; Dilauro M; Flood TA
Eur Radiol; 2016 Feb; 26(2):592-600. PubMed ID: 26032880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
